RapidAI- Transform Neurological Diagnosis in India

RapidAI works on neurovascular and vascular AI-enhanced clinical decision support and patient workflow. It received an FDA approval for its ICH (intracranial haemorrhage) model, making it the first in the world to get a specificity of 100%. Integrated in over 2000+ hospitals across 100 countries with a major footprint in the US, RapidAI is steadily growing. From covering over 5 million scans in April last year, they have crossed 10 million scans today.

#shortsvideo #shorts #neuro #neurology #neurovascular #ai #artificialintelligence …

decision decision support diagnosis fda fda approval hospitals ich india intracranial haemorrhage major making neurovascular patient rapidai specificity support workflow world